Ibruxen (Ibrutinib) 140 MG – 120 Capsules


Ibrutinib (Ibruxen) is used to treat:

(1) Mantle Cell Lymphoma (MCL) after at least one prior therapy. (2) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL). (3) CLL/SLL with 17p deletion. (4) Waldenstrom Macroglobulinemia (WM). (5) Marginal Zone Lymphoma (MZL) after one prior anti-CD20-based therapy. (6) Chronic Graft versus Host Disease (cGVHD) in adults after other systemic therapies have failed.

Whatsapp +8801922101029